• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Biotech

    Aura Biosciences Reports Q4, Full-Year 2025 Financial Results

    GLOBENEWSWIRE

    Aura Biosciences To Participate In Upcoming Investor Conferences

    GLOBENEWSWIRE

    Aura Biosciences Unveils Q3 2025 Financials And Business Updates

    GLOBENEWSWIRE

    Aura Bio to Attend H.C. Wainwright Global Investment Conference

    GLOBENEWSWIRE

    Aura Biosciences Q2 2025 Financial Results and Highlights

    GLOBENEWSWIRE

    Aura Biosciences Plans Public Offering of Stock and Warrants

    GLOBENEWSWIRE

    Aura Bio Prices Public Offering of Common Stock & Warrants

    GLOBENEWSWIRE

    Aura Biosciences Reports Q1 2025 Financial Results and Highlights

    GLOBENEWSWIRE

    Aura Biosciences to Participate in Upcoming Investor Conferences

    GLOBENEWSWIRE

    Aura Biosciences Appoints Teresa Bitetti to Board

    GLOBENEWSWIRE

    Aura Biosciences Reports Q4 and Full Year 2024 Financial Results

    GLOBENEWSWIRE

    Aura To Present Ph1 Bladder Cancer Data At EAU 2025

    GLOBENEWSWIRE

    Aura Biosciences to Participate in Upcoming Investor Conferences

    GLOBENEWSWIRE

    Aura Bio to Participate in Evercore ISI HealthCONx Conference

    GLOBENEWSWIRE

    Aura Biosciences Reports Q3 2024 Financial Results & Business

    GLOBENEWSWIRE

    With ph. 1 data, Aura has an eye on early-stage bladder cancer

    FIERCE BIOTECH

    Single Low Dose Bel-sar Shows Responses In Bladder Cancer Trial

    GLOBENEWSWIRE

    Aura Reports Positive Phase 2 Results For Bel-sar In Choroidal Melanoma

    GLOBENEWSWIRE

    Aura Biosciences to Present NMIBC Data at Urologic Oncology Event Oct 17

    GLOBENEWSWIRE

    Aura Biosciences to Participate in Upcoming Investor Conferences

    GLOBENEWSWIRE

    Aura Presents Phase 2 Data on Bel-sar for Choroidal Melanoma at Retina Society

    GLOBENEWSWIRE

    Aura Biosciences Presents Phase 2 Data On Bel-Sar For Choroidal Melanoma

    GLOBENEWSWIRE

    Aura Biosciences Reports Q2 2024 Results And Business Highlights

    GLOBENEWSWIRE

    Aura Biosciences Q1 2024 Financials And Business Highlights

    GLOBENEWSWIRE

    Aura Biosciences Announces Positive PII Safety Data of Belzupacap Sarotalocan

    BUSINESSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.